The use of opioids and opioid dependence has increased significantly, leading to a burden on patients, employers, insurers, society, and the entire healthcare system.
It is imperative that opioid dependence is addressed and treated properly, in order to return patients to being productive participants in the workplace and society.
Opioid use and dependence has increased significantly, leading to a burden on patients, employers, insurers, society, and the entire health care system. It is imperative that opioid dependence is addressed and treated properly, in order to return patients to being productive participants in the workplace and society.
Neolytica’s Ti Risk aims to identify prescribers and patients who are potentially involved in the diversion of opioids by following the entire patient journey and prescriber’s behavior, along with supplementary secondary research.
Neolytica conducts research on HCPs With “very high” risk score and provides investigation assistance by client request.
We conduct “At Risk” scoring analysis 3 times per year based on client-supplied updated data.
Our research triggers client decision to include/exclude prescriber from call list.
Resource support in client investigations of disbarment, legal proceedings & negative articles or reporting in local media.
Resource support in client investigations of disbarment, legal proceedings & negative articles or reporting in local media.
Identify physicians who exhibit suspicious prescribing behavior and to identify physicians who are embedded in a network of suspicious patients.
Use client-supplied weekly prescription data to identify physicians who continue or start suspicious prescribing behavior.
